XENE Return on Tangible Equity | XENON PHARMACEUTICALS INC.

XENON PHARMACEUTICALS INC. (XENE) Return on Tangible Equity

2026-06-30: Return Tang Equity -32.94%.
2026-03-31: Return Tang Equity -28.64%.
2025-12-31: Return Tang Equity -59.46%.
2025-09-30: Return Tang Equity -54.75%.

Complete source-backed return tang equity history.

Available history: 2012-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-32.94%
2026-03-31	-28.64%
2025-12-31	-59.46%
2025-09-30	-54.75%
2025-06-30	-43.89%
2025-03-31	-35.72%
2024-12-31	-31.04%
2024-09-30	-26.75%
2024-06-30	-23.58%
2024-03-31	-21.25%
2023-12-31	-19.66%
2023-09-30	-27.50%
2023-06-30	-25.33%
2023-03-31	-21.46%
2022-12-31	-17.38%
2022-09-30	-15.08%
2022-06-30	-11.69%
2022-03-31	-15.28%
2021-12-31	-14.34%
2021-09-30	-26.37%
2021-06-30	-22.98%
2021-03-31	-13.43%
2020-12-31	-16.83%
2020-09-30	-15.32%
2020-06-30	-14.74%
2020-03-31	-20.08%
2019-12-31	-45.22%
2019-09-30	-52.00%
2019-06-30	-53.50%
2019-03-31	-45.59%
2018-12-31	-33.40%
2018-09-30	-30.59%
2018-06-30	-54.05%
2018-03-31	-94.54%
2017-12-31	-85.45%
2017-09-30	-66.15%
2017-06-30	-56.72%
2017-03-31	-47.65%
2016-12-31	-35.99%
2016-09-30	-30.20%
2016-06-30	-32.37%
2016-03-31	-16.95%
2015-12-31	-25.81%
2015-09-30	-16.43%
2015-06-30	3.77%
2015-03-31	3.61%
2014-12-31	17.89%
2014-09-30	-21.19%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-59.46%
2024-12-31	-31.04%
2023-12-31	-19.66%
2022-12-31	-17.38%
2021-12-31	-14.34%
2020-12-31	-16.83%
2019-12-31	-45.22%
2018-12-31	-33.40%
2017-12-31	-85.45%
2016-12-31	-35.99%
2015-12-31	-25.81%
2014-12-31	17.89%
2013-12-31	-15.35%
2012-12-31	4.79%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Organon & Co. (OGN)	United States	$3.603B	17.03
ACADIA PHARMACEUTICALS INC (ACAD)	United States	$3.823B	11.45
IDEAYA Biosciences, Inc. (IDYA)	United States	$3.540B	-20.52
AbCellera Biologics Inc. (ABCL)		$3.879B	-14.59
Amylyx Pharmaceuticals, Inc. (AMLX)	United States	$3.361B	-13.15
Enliven Therapeutics, Inc. (ELVN)	United States	$3.307B	-35.07
Arcutis Biotherapeutics, Inc. (ARQT)	United States	$3.303B	115.47
Tango Therapeutics, Inc. (TNGX)	United States	$4.154B	-42.53
Arcus Biosciences, Inc. (RCUS)	United States	$3.188B	-8.52
Indivior Pharmaceuticals, Inc. (INDV)		$4.250B	14.09